{"id":"https://openalex.org/W2011936103","doi":"https://doi.org/10.1089/cap.1995.5.69","title":"Risperidone Effects in Treatment-Resistant Adolescents: Preliminary Case Reports","display_name":"Risperidone Effects in Treatment-Resistant Adolescents: Preliminary Case Reports","alternate_titles":[],"publication_year":1995,"publication_date":"1995-01-01","ids":{"openalex":"https://openalex.org/W2011936103","doi":"https://doi.org/10.1089/cap.1995.5.69","mag":"2011936103"},"language":"en","primary_location":{"id":"doi:10.1089/cap.1995.5.69","doi":"https://doi.org/10.1089/cap.1995.5.69","is_oa":false,"landing_page_url":"https://doi.org/10.1089/cap.1995.5.69","pdf_url":null,"source":{"id":"https://openalex.org/S198272637","display_name":"Journal of Child and Adolescent Psychopharmacology","issn_l":"1044-5463","issn":["1044-5463","1557-8992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2011936103"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037241721","display_name":"JOVAN G. SIMEON","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"JOVAN G. SIMEON","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113672629","display_name":"NORMAND J. CARREY","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"NORMAND J. CARREY","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048203384","display_name":"Doreen M. Wiggins","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"DOREEN M. WIGGINS","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049395702","display_name":"Robert Milin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"ROBERT P. MILIN","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5128492259","display_name":"Sheik Hosenbocus","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"SHEIK N. HOSENBOCUS","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.8204,"has_fulltext":false,"cited_by_count":54,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.96423249,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":92},"biblio":{"volume":"5","issue":"1","first_page":"69","last_page":"79"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9833999872207642,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9833999872207642,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":0.0044999998062849045,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":1.0},{"id":"https://openalex.org/keywords/antipsychotic-efficacy","display_name":"antipsychotic efficacy","score":0.7459999918937683},{"id":"https://openalex.org/keywords/long-term-antipsychotic-treatment","display_name":"long-term antipsychotic treatment","score":0.7450000047683716},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.6570000052452087},{"id":"https://openalex.org/keywords/pervasive-developmental-disorders","display_name":"pervasive developmental disorders","score":0.9950000047683716},{"id":"https://openalex.org/keywords/attention-deficit-disorder","display_name":"attention deficit disorder","score":0.9919999837875366},{"id":"https://openalex.org/keywords/obsessive-compulsive-disorder","display_name":"obsessive-compulsive disorder","score":0.847000002861023},{"id":"https://openalex.org/keywords/paranoid-ideation","display_name":"paranoid ideation","score":0.9819999933242798},{"id":"https://openalex.org/keywords/mood-swings","display_name":"mood swings","score":0.9359999895095825},{"id":"https://openalex.org/keywords/sedation","display_name":"sedation","score":0.7900000214576721},{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":0.8370000123977661},{"id":"https://openalex.org/keywords/d-amphetamine","display_name":"d-amphetamine","score":0.7350000143051147},{"id":"https://openalex.org/keywords/clomipramine","display_name":"clomipramine","score":0.9079999923706055},{"id":"https://openalex.org/keywords/child-psychiatry","display_name":"child psychiatry","score":0.5360000133514404}],"concepts":[{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.9788913726806641},{"id":"https://openalex.org/C2779305415","wikidata":"https://www.wikidata.org/wiki/Q58713","display_name":"Clomipramine","level":2,"score":0.6434303522109985},{"id":"https://openalex.org/C2780616385","wikidata":"https://www.wikidata.org/wiki/Q1385411","display_name":"Extrapyramidal symptoms","level":4,"score":0.6027783155441284},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5903675556182861},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.5632629990577698},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.49983930587768555},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4862736463546753},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.48385322093963623},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.4746309518814087},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.45303308963775635},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.4339648485183716},{"id":"https://openalex.org/C2780634440","wikidata":"https://www.wikidata.org/wiki/Q408535","display_name":"Quetiapine","level":3,"score":0.4138296842575073},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19992753863334656}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1089/cap.1995.5.69","doi":"https://doi.org/10.1089/cap.1995.5.69","is_oa":false,"landing_page_url":"https://doi.org/10.1089/cap.1995.5.69","pdf_url":null,"source":{"id":"https://openalex.org/S198272637","display_name":"Journal of Child and Adolescent Psychopharmacology","issn_l":"1044-5463","issn":["1044-5463","1557-8992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":2,"referenced_works":["https://openalex.org/W195545715","https://openalex.org/W2044278535"],"related_works":["https://openalex.org/W2006354430","https://openalex.org/W2039899281","https://openalex.org/W1976211188","https://openalex.org/W2070141776","https://openalex.org/W2028118622","https://openalex.org/W3205924749","https://openalex.org/W309183277","https://openalex.org/W2060509040","https://openalex.org/W2093197498","https://openalex.org/W2991710700"],"abstract_inverted_index":{"Many":[0],"children":[1,228],"and":[2,131,155,176,179,190,202,229],"adolescents":[3,57,125],"with":[4,14,32,42,66],"a":[5,59,67,108,140,145,212],"variety":[6,141],"of":[7,22,48,54,62,79,142,147,192],"chronic":[8],"psychiatric":[9],"disorders":[10],"receive":[11],"long-term":[12],"therapy":[13],"antipsychotic":[15],"medications.":[16,45],"Clinical":[17],"case":[18],"reports":[19],"are":[20,184],"presented":[21],"seven":[23,56],"such":[24],"adolescents,":[25],"aged":[26],"11\u201317":[27],"years,":[28],"who":[29],"were":[30,115],"treated":[31],"risperidone.":[33],"All":[34],"but":[35,103,160],"one":[36],"patient":[37],"had":[38],"prior":[39],"unsuccessful":[40],"treatments":[41],"various":[43],"psychotropic":[44],"The":[46,77],"use":[47],"risperidone":[49,80,193,197],"seemed":[50,168],"effective":[51,137,203],"in":[52,58,72,92,110,138,171,194,222],"six":[53],"the":[55,96,111,188,205],"dose":[60,100],"range":[61,146],"1\u20134":[63],"mg":[64],"daily,":[65],"significant":[68,118],"therapeutic":[69],"response":[70],"appearing":[71],"1":[73],"to":[74,85,135,186,199],"3":[75,84],"weeks.":[76],"length":[78],"treatment":[81],"ranged":[82],"from":[83],"15":[86],"months.":[87],"Some":[88],"sedation/drowsiness":[89],"was":[90,105],"observed":[91],"two":[93],"patients":[94],"at":[95],"maximum":[97],"recommended":[98],"adult":[99],"(6":[101],"mg/day),":[102],"this":[104],"resolved":[106],"by":[107],"reduction":[109],"daily":[112],"dosage.":[113],"There":[114],"no":[116],"other":[117],"adverse":[119],"effects,":[120],"including":[121,129,149],"extrapyramidal":[122],"reactions.":[123],"Two":[124],"received":[126],"concomitant":[127],"medication,":[128],"d-amphetamine":[130],"clomipramine.":[132],"Risperidone":[133,166],"appeared":[134],"be":[136,200],"relieving":[139],"symptoms":[143,221],"across":[144],"diagnoses,":[148],"schizophrenia,":[150],"pervasive":[151],"developmental":[152],"disorder":[153,158,164],"(PDD),":[154],"attention":[156],"deficit":[157],"(ADD),":[159],"not":[161],"obsessive":[162],"compulsive":[163],"(OCD).":[165],"administration":[167],"most":[169],"useful":[170],"treating":[172],"paranoid":[173],"ideation,":[174],"aggressive":[175],"impulsive":[177],"behavior,":[178],"mood":[180],"swings.":[181],"Controlled":[182],"studies":[183],"needed":[185],"determine":[187],"efficacy":[189],"safety":[191],"adolescents.":[195,230],"If":[196],"proves":[198],"safe":[201],"over":[204],"long":[206],"term,":[207],"then":[208],"clinicians":[209],"may":[210],"have":[211],"relatively":[213],"nontoxic":[214],"\"antipsychotic\"":[215],"agent":[216],"that":[217],"could":[218],"relieve":[219],"disabling":[220],"nonpsychotic":[223],"as":[224,226],"well":[225],"psychotic":[227]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2011936103","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
